# FDA WARNING_LETTER - Balamurali K. Ambati , M.D., Ph.D. - April 04, 2019

Source: https://www.globalkeysolutions.net/records/warning_letter/balamurali-k-ambati-md-phd/380cc958-be30-43ee-8573-0ae5efb9001c

> FDA WARNING_LETTER for Balamurali K. Ambati , M.D., Ph.D. on April 04, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Balamurali K. Ambati , M.D., Ph.D.
- Inspection Date: 2019-04-04
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [Sherry G. Bous](https://www.globalkeysolutions.net/people/sherry-g-bous/2dd7008e-f9c9-413f-b9c8-22945fc4e42e)
- [Director ](https://www.globalkeysolutions.net/people/david-c-burrow/ad3d9e72-84f5-464c-8760-0f55d2fd7ca6)

Company: https://www.globalkeysolutions.net/companies/balamurali-k-ambati-md-phd/a6167b4b-86cb-400e-9cf2-39d29f4bffd7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c